ADMA, SDMA and L-arginine may be Novel Targets in Pharmacotherapy for Complications due to Cardiopulmonary Bypass

BACKGROUND: In this study, the effects of olmesartan therapy on asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), L-arginine and inducible nitric oxide synthase (iNOS) levels were investigated in patients undergoing cardiopulmonary bypass. METHODS: Patients were randomly allocat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahraman, Aydın, Mutlu, Emre, Aldağ, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Medical Biochemists of Serbia 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471654/
https://www.ncbi.nlm.nih.gov/pubmed/28680344
http://dx.doi.org/10.1515/jomb-2016-0025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471654/
https://www.ncbi.nlm.nih.gov/pubmed/28680344
http://dx.doi.org/10.1515/jomb-2016-0025

Ejemplares similares